BioCentury
ARTICLE | Company News

Ilex, Bioenvision to develop nucleoside analog

March 15, 2001 8:00 AM UTC

ILXO and BIOV will co-develop BIOV's clofarabine nucleoside analog to treat hematological malignancies, such as acute lymphocytic leukemia (ALL) and acute myelogenous leukemia (AML), and solid tumors....